99 related articles for article (PubMed ID: 26616817)
1. [Predictive factors for locally recurrent rectal cancer after primary curative surgery].
Gao H; Zhang T; Zhao R
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Nov; 18(11):1176-9. PubMed ID: 26616817
[TBL] [Abstract][Full Text] [Related]
2. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
[TBL] [Abstract][Full Text] [Related]
3. Modern multidisciplinary treatment of rectal cancer based on staging with magnetic resonance imaging leads to excellent local control, but distant control remains a challenge.
Engelen SM; Maas M; Lahaye MJ; Leijtens JW; van Berlo CL; Jansen RL; Breukink SO; Dejong CH; van de Velde CJ; Beets-Tan RG; Beets GL
Eur J Cancer; 2013 Jul; 49(10):2311-20. PubMed ID: 23571146
[TBL] [Abstract][Full Text] [Related]
4. Continuous Effect of Radial Resection Margin on Recurrence and Survival in Rectal Cancer Patients Who Receive Preoperative Chemoradiation and Curative Surgery: A Multicenter Retrospective Analysis.
Sung S; Kim SH; Lee JH; Nam TK; Jeong S; Jang HS; Song JH; Lee JW; Bae JM; Lee JH
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):647-653. PubMed ID: 28581407
[TBL] [Abstract][Full Text] [Related]
5. Do t3 rectal cancers always need radiochemotherapy?
Glynne-Jones R
Recent Results Cancer Res; 2014; 203():95-115. PubMed ID: 25103002
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
[TBL] [Abstract][Full Text] [Related]
7. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?
Mawdsley S; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Osborne M; Livingstone JI; MacDonald P; Mitchell IC; Meyrick-Thomas J; Northover JM; Windsor A; Novell R; Wallace M
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):745-52. PubMed ID: 16199310
[TBL] [Abstract][Full Text] [Related]
8. Is neoadjuvant chemoradiotherapy always necessary for mid/high local advanced rectal cancer: A comparative analysis after propensity score matching.
Zhang Y; Sun Y; Xu Z; Chi P; Lu X
Eur J Surg Oncol; 2017 Aug; 43(8):1440-1446. PubMed ID: 28502421
[TBL] [Abstract][Full Text] [Related]
9. [Application of magnetic resonance in "non-operative treatment" strategy for rectal cancer].
Wang Y; Chen G
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):630-634. PubMed ID: 28643307
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of Chemoradiotherapy for the Treatment of Local Recurrence in Rectal Cancer-A Case Report].
Hara K; Yamada T; Koizumi M; Shinji S; Matsuda A; Oota R; Takahashi G; Hotta M; Takeda K; Ueda K; Kuriyama S; Yoshida H
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2143-2145. PubMed ID: 32156859
[TBL] [Abstract][Full Text] [Related]
11. Rectal cancer threatening or affecting the prostatic plane: is partial prostatectomy oncologically adequate? Results of a multicentre retrospective study.
Frasson M; Garcia-Granero E; Parajó A; Garcia-Mayor L; Flor B; Garcia-Granero A; Lavery I
Colorectal Dis; 2015 Aug; 17(8):689-97. PubMed ID: 25735444
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
13. Individualizing surgical treatment based on tumour response following neoadjuvant therapy in T4 primary rectal cancer.
Denost Q; Kontovounisios C; Rasheed S; Chevalier R; Brasio R; Capdepont M; Rullier E; Tekkis PP
Eur J Surg Oncol; 2017 Jan; 43(1):92-99. PubMed ID: 27717529
[TBL] [Abstract][Full Text] [Related]
14. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
Madbouly KM; Hussein AM; Abdelzaher E
Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
[TBL] [Abstract][Full Text] [Related]
15. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
[TBL] [Abstract][Full Text] [Related]
16. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
[TBL] [Abstract][Full Text] [Related]
17. Extramural perineural invasion in pT3 and pT4 rectal adenocarcinoma as prognostic factor after preoperative chemoradiotherapy.
Lino-Silva LS; Salcedo-Hernández RA; España-Ferrufino A; Ruiz-García EB; Ruiz-Campos M; León-Takahashi AM; Meneses-García A
Hum Pathol; 2017 Jul; 65():107-112. PubMed ID: 28526604
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of progression-free survival for locally advanced rectal cancer by MRI after neoadjuvant chemoradiotherapy and total mesorectal excision].
Zhang JX; Yang Z; Fan P; Zhang JJ; Xin L; Hou LN; Du XS; Yang XT
Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):121-126. PubMed ID: 29502372
[No Abstract] [Full Text] [Related]
19. Transanal Endoscopic Microsurgery (TEM) Following Neoadjuvant Chemoradiation for Rectal Cancer: Outcomes of Salvage Resection for Local Recurrence.
Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Fernandez LM; de Azevedo RU; Vailati BB; Fernandes FA; Gama-Rodrigues J
Ann Surg Oncol; 2016 Apr; 23(4):1143-8. PubMed ID: 26577119
[TBL] [Abstract][Full Text] [Related]
20. Patterns and prognosis of locally recurrent rectal cancer following multidisciplinary treatment.
Zhao J; Du CZ; Sun YS; Gu J
World J Gastroenterol; 2012 Dec; 18(47):7015-20. PubMed ID: 23323002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
